About PVH Staff

This author has not yet filled in any details.
So far PVH Staff has created 268 blog entries.

Press Release: Precision for Value’s Maureen Hennessey Appointed to NQF’s Medicaid Innovation Accelerator Project

2020-02-18T15:41:04+00:00News|

Quality and Population Health Expert to Serve on Coordinating Committee and Chair Physical and Mental Health Technical Expert Panel 

February 2, 2017 – New York, NY – Precision for Value, the market leader supporting global pharmaceutical companies in demonstrating the value of innovative medical products, today announced that Maureen Hennessey, SVP, Director, Quality and Population Health Systems, has been appointed to the National Quality Forum’s (NQF) Medicaid Innovation Accelerator Project 2016-2017 (IAP). She will serve on the multi-stakeholder coordinating committee and as chair of the technical expert panel (TEP) supporting physical and mental health integration.

(more…)

Precision’s Dan Renick Discusses Blocked Aetna-Humana Merger in Managed Healthcare Executive

2020-02-18T15:41:04+00:00News|

Precision for Value president Dan Renick discusses the fallout from the recently blocked merger between Aetna and Humana, in the latest edition of Managed Healthcare Executive.

How FDAMA Section 114 Helps Pharma Inform Payers

2020-02-18T15:41:04+00:00Case Studies|

Section 114 of the Food and Drug Administration Modernization Act of 1997 (FDAMA) was designed to allow pharmaceutical manufacturers to share health economic information with payers. This study shows how, by working in partnership with a pharmaceutical manufacturer, our scientists assessed COPD-related outcomes based on administrative claims data among combination therapy–naive patients—and enabled the client to engage payers on the benefits of its treatment.

Press Release: Precision for Value Strengthens and Expands Industry-Leading Payer Strategy Team

2020-02-18T15:41:04+00:00News|

Tapping Former Payer Decision Makers Brings Unrivaled Insights to Clients

 January 5, 2017 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in demonstrating the value and outcomes of innovative medical products, today announced major additions to its Payer Strategy Team with the hiring and promotion of several key executives.

Addressing the pharmaceutical industry’s urgent need to leverage real-world market insights in response to growing government and payer scrutiny over drug pricing and access, Precision for Value (Precision) has strategically assembled an industry-leading team of former payer decision makers with a direct understanding of the evolving drug marketplace, as well as strong ties to their current industry counterparts. By understanding how payers measure value and the supporting evidence, Precision has helped dozens of clients secure desired levels of market access for their innovative medical treatments.

(more…)

Precision’s Anupam Jena Named One of the 60 Most Powerful People in Healthcare for 2016

2020-02-18T15:41:04+00:00News|

Precision is proud to announce that PHE scientific advisor Anupam Jena, MD has been named by Becker’s Hospital Review as one of the 60 most powerful people in healthcare in 2016, joining other influential leaders such as Robert Califf, Frances Collins, David Feinberg, Bill & Melinda Gates, Barack Obama, and Donald Trump. Included in their annual list, Dr. Jena was recognized in part for his study published this year in JAMA that found female physicians at some of the nation’s most prominent public medical schools earn nearly $20,000 less a year on average than their male colleagues.

Congratulations, Dr. Jena!

Briefing: “Care Creativity” Innovations Transform Medicare Advantage Five-Star Plans

2020-02-18T15:41:04+00:00Thought Leadership|

Precision for Value’s Maureen Hennessey and Larry Blandford examine Medicare Advantage Five-Star Plans, focusing on innovation– in the this edition of Journal of Clinical Pathways (JCP).

(more…)

Commentary: How We Should Pay for Cures, According to Economics

2020-02-18T15:41:05+00:00Thought Leadership|

PHE Senior Research Economist Jason Shafrin’s latest Op-ed is featured in The Washington Post, as part of their “In Theory” series. The commentary, “How we should pay for cures, according to economics,” examines the current complexities of drug pricing and advocates for value-based pricing structures.

Press Release: Precision for Value Relocates NYC Office to Accommodate Rapid Growth and Expanding Talent

2020-02-18T15:41:05+00:00News|

New Office Space at One Grand Central Place Bolsters Square Feet to Nearly 18,000 

December 8, 2016 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in achieving commercial excellence, announced the move of its New York City office into a larger location in midtown Manhattan to accommodate rapid growth and an expanding workforce. The office will now be located in One Grand Central Place at 60 East 42nd Street. The nearly 18,000 square foot space will be home to over 80 employees.

(more…)

Load More Posts